ORIGINAL ARTICLE Reproductive biology Mutations in the PTEN tumor gene and risk of endometriosis: a case–control study
article
OA: closed
CC0
AI-generated summary
This case-control study found that loss of heterozygosity at the PTEN gene locus, somatic mutations in PTEN, and altered protein levels in the PTEN-PI3K/Akt pathway are associated with endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
study question: Are mutations in the phosphatase and tensin homolog deleted on chromosome 10 (PTEN) gene associated with endometriosis? summaryanswer: Loss of heterozygosity (LOH) at the10q23.3 locus, PTEN somaticmutations and changes in the levels and distribution of proteins in the PTEN-PI3K/Akt signal transduction pathway are associated with endometriosis. what is knownalready: Endometriosis has a stronggeneticbasis. Recent genome-wideassociation and linkage studieshavereported a significant association of endometriosis with 7p15.2, 9p21 and 10q23-26 loci. PTEN, which maps to 10q23.3, acts as a tumor suppressor gene through the action of its phosphatase protein product, phosphatase and tensin homolog (PTEN). This phosphatase is involved in the regulation of the cell cycle, and mutations of PTEN are a step in the development of many cancers.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-05-11T03:49:50.569207+00:00
License: CC0
· commercial use OK